Hennessy Advisors’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
Hennessy Advisors's PAHC Position: Q3 2026 in Review
Hennessy Advisors reduced its Phibro Animal Health (PAHC) stake by 8.9% in Q3 2026, selling an estimated $692K and leaving 202,000 shares worth $7.22M. The position accounts for 0.27% of the portfolio, ranked #112.
Hennessy Advisors first reported a position in PAHC in Q2 2026 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.
- Hennessy Advisors held 202,000 shares of Phibro Animal Health worth $7.22M as of Q3 2026.
- Hennessy Advisors sold 19,700 Phibro Animal Health shares in Q3 2026, an estimated $692K.
- Phibro Animal Health made up 0.27% of Hennessy Advisors's portfolio in Q3 2026, its #112 holding.
- Hennessy Advisors first reported a position in Phibro Animal Health in Q2 2026 and has held it in 2 quarters since.
- 202 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.
Based on Hennessy Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.